What is Evidium?
Evidium operates at the intersection of healthcare and artificial intelligence, providing a sophisticated platform that converts static medical knowledge into dynamic computational intelligence. The company specializes in connecting care and coverage through clear, shareable, and explainable insights. By augmenting large language models with transparent reasoning, Evidium addresses the critical industry challenge of fragmented clinical data. Their technology models patient journeys grounded in established guidelines and evidence, effectively delivering foresight across disease management, care delivery, and cost optimization. This unique approach enables healthcare organizations to make faster, more informed decisions, ultimately improving outcomes and operational efficiency.
How much funding has Evidium raised?
Evidium has raised a total of $22M across 1 funding round:
Series A
$22M
Series A (2025): $22M with participation from Health2047, Mindset Ventures, and Interwoven Ventures
Key Investors in Evidium
Health2047
Health2047 is a venture studio powered by the American Medical Association that focuses on founding, funding, and scaling companies to transform healthcare through technology and improved care delivery.
Mindset Ventures
Mindset Ventures is a venture capital firm focused on early-stage B2B startups in sectors such as Healthcare and Enterprise Software, providing founders with access to advisors and global market connections.
Interwoven Ventures
Interwoven Ventures is an early-stage venture capital firm specializing in robotics, artificial intelligence, and healthcare technology, offering strategic guidance and operational expertise to high-growth companies.
What's next for Evidium?
With this major enterprise-level funding, Evidium is poised to expand its footprint in the healthcare technology landscape. The strategic roadmap likely involves deepening the integration of its AI models with existing clinical workflows and scaling its reach to broader healthcare systems. By focusing on the intersection of evidence-based medicine and advanced machine learning, the company is well-positioned to lead the transition toward more transparent and explainable AI in clinical settings. Future growth will likely center on enhancing the platform's predictive capabilities, allowing for more granular analysis of patient outcomes and cost-efficiency metrics, thereby solidifying its role as an essential partner for healthcare providers and payers alike.
See full Evidium company page
